• 1. Fc microparticles can modulate the physical extent and magnitude of complement activity?
  David White,Sean R. Stowell Biomater. Sci., 2017,5, 463-474
• 2. Establishing plasmon contribution to chemical reactions: alkoxyamines as a thermal probe?
  Olga Guselnikova,Gérard Audran,Jean-Patrick Joly,Andrii Trelin,Evgeny V. Tretyakov,Vaclav Svorcik,Oleksiy Lyutakov,Sylvain R. A. Marque Chem. Sci., 2021,12, 4154-4161
• 3. Fe(ii)-Assisted one-pot synthesis of ultra-small core–shell Au–Pt nanoparticles as superior catalysts towards the HER and ORR?
  Yi Cao,Yujiao Xiahou,Lixiang Xing,Xiang Zhang,Hong Li,ChenShou Wu,Haibing Xia Nanoscale, 2020,12, 20456-20466
• 4. Empowering microfluidics by micro-3D printing and solution-based mineral coating?
  Hongxia Li,Aikifa Raza,Qiaoyu Ge,Jin-You Lu,TieJun Zhang Soft Matter, 2020,16, 6841-6849
• 5. Emergence of microfluidic wearable technologies
  Joo Chuan Yeo,Kenry Lab Chip, 2016,16, 4082-4090

• Solvents and Organic Chemicals Organic Compounds Lipids and lipid-like molecules Glycerolipids Diradylglycerols Diacylglycerols

Professional Introduction to 3-Stearo-1-olein (CAS No: 18266-27-8)

3-Stearo-1-olein, chemically known as (E)-9-octadecenoic acid, 3-hydroxy-, is a naturally occurring unsaturated fatty acid derivative with significant applications in the field of pharmaceuticals, cosmetics, and industrial chemistry. This compound, identified by its unique Chemical Abstracts Service (CAS) number 18266-27-8, is a member of the olein family, distinguished by its specific stereochemical configuration. The presence of a hydroxyl group at the third carbon position and a double bond at the first carbon position imparts unique physicochemical properties that make it a valuable intermediate in synthetic chemistry and a potential candidate for various biological applications.

The structure of 3-Stearo-1-olein consists of a long hydrocarbon chain with a hydroxyl group at the third carbon and an (E)-double bond at the first carbon. This configuration contributes to its relatively high melting point compared to other unsaturated fatty acids, making it useful in formulations where stability at lower temperatures is required. The compound's ability to form esters and other derivatives further enhances its utility in pharmaceutical synthesis, particularly in the development of lipid-based drug delivery systems.

In recent years, 3-Stearo-1-olein has garnered attention in the field of lipid-based drug delivery due to its ability to enhance the bioavailability of hydrophobic drugs. Research has demonstrated that incorporating this compound into nanocarriers such as liposomes and micelles can significantly improve drug solubility and targeted delivery. For instance, studies have shown that when used in combination with anti-cancer agents, 3-Stearo-1-olein-based formulations exhibit improved pharmacokinetic profiles, leading to higher therapeutic efficacy and reduced side effects.

The compound's role in regenerative medicine is another area of active investigation. Its structural properties allow it to interact with cellular membranes, potentially influencing cell signaling pathways involved in tissue repair and regeneration. Preliminary studies have suggested that 3-Stearo-1-olein can modulate the activity of certain enzymes and receptors, making it a promising candidate for developing therapeutic agents that promote wound healing and tissue regeneration.

In the realm of cosmetics, 3-Stearo-1-olein is valued for its emollient and moisturizing properties. Its ability to penetrate the skin barrier makes it an effective component in skincare formulations aimed at hydrating and softening the skin. Additionally, its anti-inflammatory properties have been explored in topical treatments for conditions such as eczema and psoriasis. The compound's compatibility with other cosmetic ingredients further enhances its appeal as an additive in high-end skincare products.

The industrial applications of 3-Stearo-1-olein are equally diverse. In polymer chemistry, it serves as a monomer or modifier for biodegradable plastics, contributing to sustainable materials development. Its use in lubricants and greases is also noteworthy due to its ability to reduce friction and wear on mechanical components. These applications underscore the compound's versatility beyond pharmaceuticals and cosmetics.

The synthesis of 3-Stearo-1-olein typically involves catalytic hydrogenation or enzymatic processes that preserve its stereochemical integrity. Advances in biocatalysis have enabled more efficient and environmentally friendly production methods, reducing reliance on harsh chemical conditions. These innovations not only improve yield but also minimize waste generation, aligning with global sustainability goals.

Ongoing research continues to uncover new potential applications for 3-Stearo-1-olein. For example, studies are exploring its role in managing metabolic disorders by investigating how it interacts with lipid metabolism pathways. The compound's ability to influence cholesterol levels and insulin sensitivity positions it as a candidate for developing novel therapeutic strategies for diabetes and related metabolic conditions.

The regulatory landscape for compounds like 3-Stearo-1-olein is continually evolving. As new applications emerge, regulatory agencies are adapting guidelines to ensure safety and efficacy across diverse uses. Manufacturers must navigate these evolving regulations carefully to bring innovative products to market while maintaining compliance with international standards.

In conclusion, 3-Stearo-1-olein (CAS No: 18266-27-8) is a multifaceted compound with broad applications spanning pharmaceuticals, cosmetics, and industrial chemistry. Its unique structural properties enable diverse functionalities, from enhancing drug delivery systems to promoting skin health and sustainable materials development. As research advances, the potential uses of this compound are expected to expand further, reinforcing its importance in modern science and industry.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)